A meta-analysis of the prognostic significance of atrial fibrillation in chronic heart failure

European Journal of Heart Failure

Volumn 11, Issue 7, 2009, Pages 676-683

  Mamas, Mamas A ^a,b   Caldwell, Jane C ^a,b   Chacko, Sanoj ^b   Garratt, Clifford J ^a,b   Fath Ordoubadi, Farzin ^b   Neyses, Ludwig ^a,b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Atrial fibrillation; Heart failure; Meta analysis; Mortality

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART LEFT VENTRICLE CONTRACTION; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; AGED; CONFIDENCE INTERVAL; FEMALE; HEART LEFT VENTRICLE FUNCTION; MALE; META ANALYSIS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK; RISK ASSESSMENT; SYSTOLIC HEART FAILURE; UNITED KINGDOM;

AGED; ATRIAL FIBRILLATION; CONFIDENCE INTERVALS; FEMALE; GREAT BRITAIN; HEART FAILURE; HEART FAILURE, SYSTOLIC; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ASSESSMENT; VENTRICULAR FUNCTION, LEFT;

EID: 67650034881     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1093/eurjhf/hfp085     Document Type: Article

References (27)

1. Maisel WH, Stevenson LW. Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy. Am J Cardiol 2003; 91:2-8.
2. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991; 325:293-302.
3. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).. N Engl J Med 1987; 316:1429-1435.
4. Rivero-Ayerza M, Scholte op Reimer W, Lenzen M, Theuns DAMJ, Jordaens L, Komajda M, Follath F, Swedberg K, Cleland JGF. New-onset atrial fibrillation is an independent predictor of in-hospital mortality in hospitalized heart failure patients: results of the EuroHeart Failure Survey. Eur Heart J 2008; 29:1618-1624.
5. Cleland JGF, Swedberg K, Follath F, Komajda M, Cohen-Solal A, Aguilar JC,Dietz R, Gavazzi A, Hobbs R, Korewicki J, Madeira HC, Moiseyev VS, Preda I, van Gilst WH, Widimsky J, for the Study Group on Diagnosis of the Working Group on Heart Failure of the European Society of Cardiology, Freemantle N, Eastaugh J, Mason J. The EuroHeart Failure survey programmea survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. Eur Heart J 2003; 24:442 -463.
6. Dries DL, Exner DV, Gersh BJ, Domanski MJ, Waclawiw MA, Stevenson LW. Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. J Am Coll Card1998; 32:695-703.
7. Carson PE, Johnson GR, Dunkman WB, Fletcher RD, Farrell L, Cohn JN. The influence of atrial fibrillation on prognosis in mild to moderate heart failure. The V-HeFT Studies. The V-HeFT VA Cooperative Studies Group. Circulation 1993; 87:VI102-VI110.
8. Mahoney P, Kimmel S, DeNofrio D, Wahl P, Loh E. Prognostic significance of atrial fibrillation in patients at a tertiary medical center referred for heart transplantation because of severe heart failure. Am J Cardiol 1999; 83:1544-1547.
9. Pai RG, Varadarajan P. Prognostic significance of atrial fibrillation is a function of left ventricular ejection fraction. Clin Cardiol 2007; 30:349-354.
10. Olsson LG, Swedberg K, Ducharme A, Granger CB, Michelson EL, McMurray JJV, Puu M, Yusuf S, Pfeffer MA. Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the candesartan in heart failureassessment of reduction in mortality and morbidity (CHARM) program. JAm Coll Card 2006; 47:1997-2004.
11. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Lancet 1999; 354:1896-1900.
12. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D,Becker BJ, Sipe TA, Thacker SB, for the Meta-analysis Of Observational Studies in Epidemiology Group. Meta-analysis of observational studies in epidemiology:a proposal for reporting. JAMA 2000; 283:2008-2012.
13. Mathew J, Hunsberger S, Fleg J, Mc Sherry F, Williford W, YusufS. Incidence, predictive factors, and prognostic significance of supraventricular tachyarrhythmias in ongestive heart failure. Chest 2000; 118:914-922.
14. Pedersen OD, Sondergaard P, Nielsen T, Nielsen SJ, Nielsen ES, Falstie-Jensen N, Nielsen I, Kober L, Burchardt H, Seibaek M, Torp-Pedersen C, on behalf of the DIAMOND study group investigators. Atrial fibrillation, ischaemic heart disease, and the risk of death in patients with heart failure. Eur Heart J2006; 27:2866-2870.
15. Crijns HJGM, Tjeerdsma G, de Kam PJ, Boomsma F, Van Gelder IC, van den Berg MP, van Veldhuisen DJ. Prognostic value of the presence and development of atrial fibrillation in patients with advanced chronic heart failure. Eur Heart J2000; 21:1238-1245.
16. Swedberg K, Olsson LG, Charlesworth A, Cleland J, Hanrath P, Komajda M, Metra M, Torp-Pedersen C, Poole-Wilson P. Prognostic relevance of atrial fibrillation in patients with chronic heart failure on long-term treatment with beta-blockers: results from COMET. Eur Heart J2005; 26:1303 -1308.
17. Middlekauff HR, Stevenson WG, Stevenson LW. Prognostic significance of atrial fibrillation in advanced heart failure. A study of 390 patients. Circulation 1991;84:40-48.
18. Stevenson WG, Stevenson LW, Middlekauff HR, Fonarow GC, Hamilton MA, Woo MA, Saxon LA, Natterson PD, Steimle A, Walden JA, Tillisch JH. Improving survival for patients with atrial fibrillation and advanced heart failure. J Am Coll Card 1996; 28:1458-1463.
19. Rusinaru D, Leborgne L, Peltier M, Tribouilloy C. Effect of atrial fibrillation on long-term survival in patients hospitalised for heart failure with preserved ejection fraction. Eur JHeart Fail 2008; 10:566-572.
20. Ahmed A, Thornton P, Perry GJ, Allman RM, DeLong JF. Impact of atrial fibrillation on mortality and readmission in older adults hospitalized with heart failure. Eur JHeart Fail 2004; 6:421 -426.
21. Wojtkowska I, Sobkowicz B, Musial WJ, Kozuch M. Persistent atrial fibrillation as a prognostic factor of outcome in patients with advanced heart failure. Kardiol Pol2006; 64:777-783.
22. Corell P, Gustafsson F, Schou M, Markenvard J, Nielsen T, Hildebrandt P. Prevalence and prognostic significance of atrial fibrillation in outpatients with heart failure due to left ventricular systolic dysfunction. Eur JHeart Fail 2007; 9:258-265.
23. Clark DM, Plumb VJ, Epstein AE, Kay GN. Hemodynamic Effects of an irregular sequence of ventricular cycle lengths during atrial fibrillation. J Am Coll Card1997; 30:1039-1045.
24. Pozzoli M, Cioffi G, Traversi E, Pinna GD, Cobelli F, Tavazzi L. Predictors of primary atrial fibrillation and concomitant clinical and hemodynamic changes in patients with chronic heart failure: a prospective study in 344 patients with baseline sinus rhythm. JAm Coll Card 1998; 32:197-204.
25. RoyD, Talajic M, Nattel S, Wyse DG, Dorian P, Lee KL, Bourassa MG, Arnold JM,Buxton AE, Camm AJ, Connolly SJ, Dubuc M, Ducharme A, Guerra PG, Hohnloser SH, Lambert J, Le Heuzey JY, O'Hara G, Pedersen OD, Rouleau JL,Singh BN, Stevenson LW, Stevenson WG, Thibault B, Waldo AL, the Atrial Fibrillation Congestive Heart Failure Investigators. Rhythm control versus rate control for atrial fibrillation and heart failure. N Engl J Med 2008; 358:2667-2677.
26. Pedersen OD, Bagger H, Keller N, Marchant B, Kober L, Torp-Pedersen C. Efficacy of dofetilide in the treatment of atrial fibrillation-flutter in patients with reduced left ventricular function: a Danish investigations of arrhythmia and mortality on dofetilide (diamond) substudy. Circulation 2001; 104:292-296.
27. Caldwell JC, Contractor H, Garratt CJ, Neyses L, Mamas M. Burden of asymptomatic episodes of atrial fibrillation in a heart failure cohort. Eur J Heart Fail Suppl 2008; 7:161 -161.